Phase 1 COVID-19 Data and Connectivity – National Core Study (Phase 1 D&C-NCS)

第 1 阶段 COVID-19 数据和连接 — 国家核心研究(第 1 阶段 D

基本信息

  • 批准号:
    MC_PC_20058
  • 负责人:
  • 金额:
    $ 1936.78万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Intramural
  • 财政年份:
    2021
  • 资助国家:
    英国
  • 起止时间:
    2021 至 无数据
  • 项目状态:
    已结题

项目摘要

The Data and Connectivity study sits across the other National Core Studies and delivers a national health data research capability to support COVID-19 research questions, ensuring datasets are discoverable and accessible and linkages are established to answer the priority research questions from the other five National Core Studies. Making data available for wider research use will increase the scope of benefits beyond the specific studies above, leading to unexpected benefits and boosting UK research capacity more generally, increasing return on investment for the NCS programme. Data integration and harmonisation of methods and standards will enable rapid research and development of new interventions and technologies across the spectrum of COVID-19, and knowledge and technology transfer to other clinical and public health areas. Collation and linkage between datasets is critical to bringing the core studies together, ensuring that each of them can deliver against their policy priorities e.g. hospital data may not currently be linked with GP data and wider community data (e.g. socioeconomic data or data on housing and the built environment). Access, cleaning, linkage and use of these datasets together is needed to fully understand links between these factors and outcomes.Delivery of the COVID-19 Data and Connectivity Study will involve close interaction with data custodians, the public and patients, and providers of UK-wide national Trusted Research Environments (TREs) to ensure the required data is stored safely and securely, made readily available to approved researchers and is associated with compute, analytical and data services that make it easier to address priority research questions in a transparent and trustworthy way.Phase 1 will:• Continue to respond to emerging COVID-19 research priorities, mapping key datasets required by the National Core Studies, NIHR UPH Studies and SAGE sub-groups to allow research which can inform policy and operational decision making across the UK• Further develop the data infrastructure and services across the UK to allow faster access to high priority health, administrative, molecular, and behavioural data assets for researchers working on the most important COVID-related studies, ensuring priority research questions can be answered efficiently, in a transparent and trustworthy way. • Strengthen and extend the existing national Trusted Research Environments (TRE) and UK Health Data Research Innovation Gateway infrastructure through inclusive four nations approach ensuring the priority datasets for COVID-19 research are findable, accessible, inter-operable and reusable (FAIR) as a single shop window
数据和连通性研究位于其他国家核心研究中,并提供了国家卫生数据研究能力,以支持COVID-19的研究问题,确保数据集可以发现并且可以访问并建立链接,以回答其他五个国家核心研究的优先研究问题。使可用于更广泛的研究使用的数据将增加以外的特定研究的范围,从而更加普遍地提高英国研究能力,从而增加NCS计划的投资回报率。方法和标准的数据整合和协调将使COVID-19的新干预措施和技术以及知识和技术转移到其他临床和公共卫生领域的新干预措施和技术的快速研究和开发。数据集之间的整理和链接对于将核心研究结合在一起至关重要,确保每个数据都可以违反其政策优先事项,例如医院数据目前可能没有与GP数据和更广泛的社区数据联系起来(例如,有关住房和建筑环境的数据)。需要将这些数据集的访问,清洁,链接和使用在一起,以完全了解这些因素和结果之间的联系。送达COVID-19-19和连通性研究将涉及与数据保管人,公众和患者,公众和患者以及英国范围内的国家信任研究环境(TRES)的数据,以确保可依靠的数据与数据相关联,以确保可行的数据与数据相关联,以确保可供应的数据与数据相关联。 it easier to address priority research questions in a transparent and trustworthy way.Phase 1 will:• Continue to respond to emerging COVID-19 research priorities, mapping key datasets required by the National Core Studies, NIHR UPH Studies and SAGE sub-groups to allow research which can inform policy and operational decision making across the UK• Further developing the data infrastructure and services across the UK to allow faster access to high priority health, administrative, molecular, and针对从事最重要相关研究的研究人员的行为数据资产,确保优先研究问题可以以透明和值得信赖的方式有效地回答。 •通过包含四个国家的方法加强和扩展现有的国家信任研究环境(TRE)和英国健康数据研究创新基础架构,以确保可访问Covid-19的优先数据集,可访问,可访问,可重复使用且可重复使用(公平)作为单个商店的窗口

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration.
  • DOI:
    10.1186/s12911-022-02093-0
  • 发表时间:
    2023-01-16
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Abbasizanjani, Hoda;Torabi, Fatemeh;Bedston, Stuart;Bolton, Thomas;Davies, Gareth;Denaxas, Spiros;Griffiths, Rowena;Herbert, Laura;Hollings, Sam;Keene, Spencer;Khunti, Kamlesh;Lowthian, Emily;Lyons, Jane;Mizani, Mehrdad A.;Nolan, John;Sudlow, Cathie;Walker, Venexia;Whiteley, William;Wood, Angela;Akbari, Ashley
  • 通讯作者:
    Akbari, Ashley
Towards mitigating health inequity via machine learning: a nationwide cohort study to develop and validate ethnicity-specific models for prediction of cardiovascular disease risk in COVID-19 patients
通过机器学习减轻健康不平等:一项全国性队列研究,旨在开发和验证用于预测 COVID-19 患者心血管疾病风险的特定种族模型
  • DOI:
    10.1101/2023.09.13.23295489
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Allery F
  • 通讯作者:
    Allery F
Harmonising electronic health records for reproducible research: challenges, solutions and recommendations from a UK-wide COVID-19 research collaboration
协调电子健康记录以进行可重复的研究:英国范围内的 COVID-19 研究合作面临的挑战、解决方案和建议
  • DOI:
    10.21203/rs.3.rs-2109276/v1
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Abbasizanjani H
  • 通讯作者:
    Abbasizanjani H
Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland.
  • DOI:
    10.1136/jech-2023-220501
  • 发表时间:
    2023-10
  • 期刊:
  • 影响因子:
    6.3
  • 作者:
    Amele, Sarah;Kibuchi, Eliud;McCabe, Ronan;Pearce, Anna;Henery, Paul;Hainey, Kirsten;Fagbamigbe, Adeniyi Francis;Kurdi, Amanj;McCowan, Colin;Simpson, Colin R.;Dibben, Chris;Buchanan, Duncan;Demou, Evangelia;Almaghrabi, Fatima;Anghelescu, Gina;Taylor, Harry;Tibble, Holly;Rudan, Igor;Nazroo, James;Becares, Laia;Daines, Luke;Irizar, Patricia;Jayacodi, Sandra;Pattaro, Serena;Sheikh, Aziz;Katikireddi, Srinivasa Vittal
  • 通讯作者:
    Katikireddi, Srinivasa Vittal
COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study.
  • DOI:
    10.1016/s2213-2600(21)00380-5
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Agrawal U;Katikireddi SV;McCowan C;Mulholland RH;Azcoaga-Lorenzo A;Amele S;Fagbamigbe AF;Vasileiou E;Grange Z;Shi T;Kerr S;Moore E;Murray JLK;Shah SA;Ritchie L;O'Reilly D;Stock SJ;Beggs J;Chuter A;Torabi F;Akbari A;Bedston S;McMenamin J;Wood R;Tang RSM;de Lusignan S;Hobbs FDR;Woolhouse M;Simpson CR;Robertson C;Sheikh A
  • 通讯作者:
    Sheikh A
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Andrew Morris其他文献

Exploration of naphthoquinone analogs in targeting the TCF-DNA interaction to inhibit the Wnt/β-catenin signaling pathway.
探索萘醌类似物靶向 TCF-DNA 相互作用以抑制 Wnt/β-catenin 信号通路。
  • DOI:
  • 发表时间:
    2022
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Andrew Morris;Rosalie G. Hoyle;P. Pagare;Shadid Uz Zaman;Zhikun Ma;Jiong Li;Yan Zhang
  • 通讯作者:
    Yan Zhang
Mapping of Internet “Coastlines” via Large Scale Anonymized Network Source Correlations
通过大规模匿名网络源关联绘制互联网“海岸线”
  • DOI:
    10.1109/hpec58863.2023.10363488
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Hayden Jananthan;J. Kepner;Michael Jones;W. Arcand;David Bestor;William Bergeron;C. Byun;Tim Davis;V. Gadepally;Daniel Grant;Michael Houle;M. Hubbell;Anna Klein;Lauren Milechin;Guillermo Morales;Andrew Morris;J. Mullen;Ritesh Patel;A. Pentland;Sandeep Pisharody;Andrew Prout;A. Reuther;Antonio Rosa;S. Samsi;Tyler H. Trigg;Gabriel Wachman;Charles Yee;P. Michaleas
  • 通讯作者:
    P. Michaleas
Creating sustainable innovation through design for behaviour change: full project report
通过行为改变设计创造可持续创新:完整的项目报告
  • DOI:
  • 发表时间:
    2014
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Niedderer;J. MacKrill;S. Clune;Dan Lockton;Geke D. S. Ludden;Andrew Morris;R. Cain;E. Gardiner;Robin Gutteridge;M. Evans;P. Hekkert
  • 通讯作者:
    P. Hekkert
Objective patient-related outcomes of rapid-response systems — a pilot study to demonstrate feasibility in two hospitals
  • DOI:
    10.1016/s1441-2772(23)02185-3
  • 发表时间:
    2013-03-01
  • 期刊:
  • 影响因子:
  • 作者:
    Andrew Morris;Helen M. Owen;Karen Jones;Jillian Hartin;John Welch;Christian P. Subbe
  • 通讯作者:
    Christian P. Subbe
Evaluation of alternative intersection treatments at rural crossroads using simulation software
  • DOI:
    10.1080/15389588.2018.1528357
  • 发表时间:
    2018-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Sujanie Peiris;Bruce Corben;Michael Nieuwesteeg;Hampton C. Gabler;Andrew Morris;Diana Bowman;Michael G. Lenné;Michael Fitzharris
  • 通讯作者:
    Michael Fitzharris

Andrew Morris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Andrew Morris', 18)}}的其他基金

Harnessing the power of diverse populations to empower clinical translation of genome-wide association studies of common human disease
利用不同人群的力量,促进人类常见疾病全基因组关联研究的临床转化
  • 批准号:
    MR/W029626/1
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
Novel statistical methods for transcriptomic imputation to enhance understanding of causal mechanisms underlying human diseases
转录组插补的新统计方法可增强对人类疾病因果机制的理解
  • 批准号:
    MR/V020749/1
  • 财政年份:
    2022
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
UKRI trusted and connected Data and Analytics Research Environments, Phase 1
UKRI 可信且互联的数据和分析研究环境,第一阶段
  • 批准号:
    MC_PC_21005
  • 财政年份:
    2021
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
Population Research UK Phase 1: Partnership Design & Dialogue
英国人口研究第一阶段:合作伙伴设计
  • 批准号:
    MC_PC_20024
  • 财政年份:
    2021
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
COVID-19: Data and Connectivity – National Core Study (D&C-NCS)
COVID-19:数据和连接 – 国家核心研究 (D
  • 批准号:
    MC_PC_20029
  • 财政年份:
    2020
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
Baskerville: a national accelerated compute resource
巴斯克维尔:国家加速计算资源
  • 批准号:
    EP/T022221/1
  • 财政年份:
    2020
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
UKRI ISCF DIH Programme Phase 3– Innovation Gateway, Health Data Research Hubs, and UK Health Data Research Alliance
UKRI ISCF DIH 计划第 3 阶段——创新网关、健康数据研究中心和英国健康数据研究联盟
  • 批准号:
    MC_PC_19002
  • 财政年份:
    2019
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural
Open KE Fellowship: Translation of a Miniature CT-DO Sensor from the Laboratory to Real World Applications
开放 KE 奖学金:微型 CT-DO 传感器从实验室到现实世界应用的转化
  • 批准号:
    NE/S006451/2
  • 财政年份:
    2019
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
Open KE Fellowship: Translation of a Miniature CT-DO Sensor from the Laboratory to Real World Applications
开放 KE 奖学金:微型 CT-DO 传感器从实验室到现实世界应用的转化
  • 批准号:
    NE/S006451/1
  • 财政年份:
    2018
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Research Grant
Health Data Research UK - CORE Funds
英国健康数据研究 - CORE 基金
  • 批准号:
    HDR-CORE
  • 财政年份:
    2018
  • 资助金额:
    $ 1936.78万
  • 项目类别:
    Intramural

相似国自然基金

CEACAM5调控Galectin-9介导的CD4+T细胞极化在COVID-19肠屏障损伤的作用机制研究
  • 批准号:
    82370569
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
COVID-19疫情对我国儿童生长发育影响的异质性研究
  • 批准号:
    42371429
  • 批准年份:
    2023
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
COVID-19中线粒体囊泡抑制CD8+T细胞记忆分化的机制研究
  • 批准号:
    82300018
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于 GDF15-IL6 信号轴探究扶正解毒方逆转血管内皮衰老治疗COVID-19的作用与机制
  • 批准号:
    82374392
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目

相似海外基金

Developing a PIV5-based human metapneumovirus (HMPV) vaccine
开发基于 PIV5 的人类偏肺病毒 (HMPV) 疫苗
  • 批准号:
    10698491
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
Improved Treatment of Colorectal Cancer with CF10
CF10 改善结直肠癌治疗
  • 批准号:
    10698394
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
  • 批准号:
    10759950
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
GENOMICE (Game Exploring Nuances in Offspring to Master Interactions of Chromosome Expression)
GENOMICE(探索后代细微差别以掌握染色体表达相互作用的游戏)
  • 批准号:
    10760456
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
Meeting the Challenges of COVID-19 by Expanding the Reach of Palliative Care: Proactive Advance Care Planning with Videos for the Elderly and all Patients with Dementia
通过扩大姑息治疗的范围来应对 COVID-19 的挑战:为老年人和所有痴呆症患者提供视频的主动预先护理计划
  • 批准号:
    10784057
  • 财政年份:
    2023
  • 资助金额:
    $ 1936.78万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了